The University of Louisville has been selected as a study site for a clinical trial researching a vaccine to prevent infection from a bacterium that primarily affects older patients in hospitals or long-term care facilities who also have taken broad-spectrum antibiotics.
http://www.infectioncontroltoday.com/news/2013/08/university-of-louisville-accepting-patients-in-study-of-c-diff-vaccine.aspx?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+News-ICT+%28ICT_News%29
http://www.infectioncontroltoday.com/news/2013/08/university-of-louisville-accepting-patients-in-study-of-c-diff-vaccine.aspx?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+News-ICT+%28ICT_News%29
No comments:
Post a Comment